These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25789519)

  • 21. Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance.
    Bonassi Machado R; Chada Baracat E; Eduardo Fernandes C; Marcelo Lakryc E; Rodrigues De Lima G
    Gynecol Endocrinol; 2007 Nov; 23(11):619-24. PubMed ID: 17907004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study.
    Walker RJ; Lewis-Barned NJ; Sutherland WH; Goulding A; Edwards EA; de Jong SA; Gold E; Walker HL
    Menopause; 2001; 8(1):27-32. PubMed ID: 11201511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
    Stevenson JC; Oladipo A; Manassiev N; Whitehead MI; Guilford S; Proudler AJ
    Br J Haematol; 2004 Mar; 124(6):802-8. PubMed ID: 15009069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
    Kurtay G; Ozmen B
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.
    Walsh BW; Paul S; Wild RA; Dean RA; Tracy RP; Cox DA; Anderson PW
    J Clin Endocrinol Metab; 2000 Jan; 85(1):214-8. PubMed ID: 10634389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
    Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
    Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
    Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
    Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in bone density and turnover after alendronate or estrogen withdrawal.
    Wasnich RD; Bagger YZ; Hosking DJ; McClung MR; Wu M; Mantz AM; Yates JJ; Ross PD; Alexandersen P; Ravn P; Christiansen C; Santora AC;
    Menopause; 2004; 11(6 Pt 1):622-30. PubMed ID: 15545790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G; Spritzer PM
    Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
    Al-Azzawi F; Wahab M; Sami S; Proudler AJ; Thompson J; Stevenson J
    Climacteric; 2004 Sep; 7(3):292-300. PubMed ID: 15669554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels.
    Yildirir A; Aybar F; Tokgozoglu L; Yarali H; Kabakci G; Bukulmez O; Sinici I; Oto A
    Gynecol Obstet Invest; 2002; 53(1):54-8. PubMed ID: 11803230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
    Bladbjerg EM; Skouby SO; Andersen LF; Jespersen J
    Hum Reprod; 2002 Dec; 17(12):3235-41. PubMed ID: 12456630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
    Cengiz B; Atabekoglu C; Cetinkaya E; Cengiz SD
    Maturitas; 2003 Dec; 46(4):301-6. PubMed ID: 14625127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women.
    Ylikorkala O; Eviö S; Välimäki M; Tiitinen A
    Fertil Steril; 2003 Sep; 80(3):541-5. PubMed ID: 12969695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hormone therapy on plasma homocysteine levels: a randomized clinical trial.
    Tutuncu L; Ergur AR; Mungen E; Gun I; Ertekin A; Yergok YZ
    Menopause; 2005 Mar; 12(2):216-22. PubMed ID: 15772570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.